Exclusive

Publication

Byline

Clinical Trial: Prevention ICONA Dedicated Ensemble

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07186244) titled 'Prevention ICONA Dedicated Ensemble' on Aug. 04. Brief Summary: Despite significant advan... Read More


Clinical Trial: LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07186101) titled 'LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severel... Read More


Clinical Trial: Feasibility of the Reality PAWS Program for Children in Isolation

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07187245) titled 'Feasibility of the Reality PAWS Program for Children in Isolation' on Sept. 10. Brief Sum... Read More


Clinical Trial: Hall Technique vs Conventional Crown Restoration in Permanent Molars: Split-Mouth Trial in Children

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07186673) titled 'Hall Technique vs Conventional Crown Restoration in Permanent Molars: Split-Mouth Trial in... Read More


Clinical Trial: An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07185165) titled 'An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Di... Read More


Clinical Trial: Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07187011) titled 'Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans' on Sept. 15... Read More


Clinical Trial: Study of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Versus Host Disease

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07185633) titled 'Study of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Vers... Read More


Moldova's election faces AI-driven disinformation from Russia

New Delhi, Sept. 23 -- Moldovans are facing a flood of disinformation driven by artificial intelligence ahead of a critical parliamentary election, which will determine whether the small country can s... Read More


ENVIRONMENTAL PROTECTION AGENCY ISSUES PROPOSED RULE: PROCEDURES FOR CHEMICAL RISK EVALUATION UNDER THE TOXIC SUBSTANCES CONTROL ACT (TSCA)

WASHINGTON, Sept. 23 -- Environmental Protection Agency has issued a proposed rule called: Procedures for Chemical Risk Evaluation Under the Toxic Substances Control Act (TSCA). The proposed rule was... Read More


FEDERAL ENERGY REGULATORY COMMISSION ISSUES PROPOSED RULE: VIRTUALIZATION RELIABILITY STANDARDS

WASHINGTON, Sept. 23 -- Federal Energy Regulatory Commission has issued a proposed rule called: Virtualization Reliability Standards. The proposed rule was published in the Federal Register on Sept. ... Read More